ResearchMoz

Browse All Vaccine Market Research Reports

List of reports from Vaccine

Displaying 1 to 30 (of 206 records)
Influenza Vaccines Market & Forecast - Worldwide Analysis
Nov 2014   |   By - Renub Research
The Influenza vaccines market represent an attractive market characterize by sturdy growth prospects. Increasing awareness, growing vaccination coverage in the emerging countries, rising government support for immunization against Seasonal Influenza and increased focus on the production of treatments for vulnerable populations by introducing new vaccines and vaccines with a better route of...
$1490
Research Report on China Avian Influenza Vaccine Industry : 2014-2018
Sep 2014   |   By - China Research and Intelligence Co., Ltd. (CRI)
Many countries choose to kill all infected poultry to control avian influenza, instead of immunizations. The total number of poultry exceeds 10 billion in China. Epidemic diseases, which are difficult to control, will result in huge losses. Therefore, it is quite necessary to immunize the poultry with avian influenza vaccines.  Avian influenza vaccines have been used for more than...
$1800
Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry : 2014-2018
Sep 2014   |   By - China Research and Intelligence Co., Ltd. (CRI)
China is the world's largest producer and consumer of pork with the output volume of pork accounting for nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY.  The PRRS broke out in...
$1800
Research Report on China Swine Fever Vaccine Industry : 2014-2018
Sep 2014   |   By - China Research and Intelligence Co., Ltd. (CRI)
China is the world's largest producer and consumer of pork with the output volume accounting nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY.  Swine fever is considered a highly...
$1800
Research Report on China Foot-and-mouth Disease (FMD) Vaccine Industry : 2014-2018
Sep 2014   |   By - China Research and Intelligence Co., Ltd. (CRI)
China is the world's largest producer and consumer of pork with the output volume accounting nearly 50% of the total. According to the statistics of agricultural production from the National Bureau of Statistics of China, the annual output volume of poultry meat was 83.73 million tons in 2013, up by 1.8% YOY. The output volume of pork was 54.93 million tons, up by 2.8%. The stock volume of...
$1800
China Human Vaccine Industry Report, 2014-2017
Sep 2014   |   By - Research In China
Vaccines can prevent and control infectious diseases, so the demand for these biological products is relatively rigid. In 2013, China’s human vaccine lot release volume grew by 4.9% from a year earlier, and the market size expanded 2.8% year on year. As vaccination is suspected of causing death and some companies (such as Shenzhen Kangtai, Tiantan Biological and Dalian Hissen) have to...
$2600
Vaccines-Pipeline Insights, 2014
Aug 2014   |   By - DelveInsight
The Report will be Dispatched in 3 Working Days.  DelveInsights, Vaccines-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Vaccines. This report provides information on the therapeutic development...
$1250
Global and Chinese Veterinary Vaccine Industry, 2009-2019 Market Research Report
Aug 2014   |   By - Prof Research
Market Research Report on Global and Chinese Veterinary Vaccine Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Veterinary Vaccine industry. The report firstly reviews the basic information of Veterinary Vaccine including its classification, application and manufacturing technology; The report then explores global and Chinas top manufacturers of Veterinary...
$2400
Immunovaccine, Inc. - Product Pipeline Review - 2014
Jul 2014   |   By - Global Markets Direct
Immunovaccine, Inc. - Product Pipeline Review - 2014 Summary Global Markets Directs, Immunovaccine, Inc. - Product Pipeline Review - 2014, provides an overview of the Immunovaccine, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Immunovaccine, Inc.s, complete with comparative analysis at...
$1500
VBI Vaccines - Product Pipeline Review - 2014
Jul 2014   |   By - Global Markets Direct
VBI Vaccines - Product Pipeline Review - 2014 Summary Global Markets Directs, VBI Vaccines - Product Pipeline Review - 2014, provides an overview of the VBI Vacciness pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of VBI Vacciness, complete with comparative analysis at various stages,...
$1500
OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020
Jul 2014   |   By - GlobalData
Dengue is a febrile illness caused by the dengue virus (DENV), a single-stranded flavivirus most commonly transmitted by the Aedes aegypti (A. aegypti) mosquito. Thought to be responsible for upwards of 100 million infections each year, DENV is the most prevalent arthropod-borne virus in the world. Individuals infected with DENV can present with a wide spectrum of symptoms, including...
$7995
Vaccine Partnering Terms and Agreements
Jul 2014   |   By - Current Partnering
The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in vaccine and adjuvant partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by...
$2995
China Animal Vaccine Industry Report, 2013-2016
Jun 2014   |   By - Research In China
Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. Europe and the United States and other developed countries are the main force of traditional animal vaccine markets in the world, still taking around 60% nowadays. In recent years, European and American animal vaccine markets have decelerated growth due to quality...
$2500
Global Encephalitis Vaccine Industry 2014 Market Research Report
Jun 2014   |   By - 9Dimen Research
was a professional and depth research report on Global Encephalitis Vaccine industry that you would know the world's major regional market conditions of Encephalitis Vaccine industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc. The report firstly introduced Encephalitis Vaccine basic information...
$2850
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany
Jun 2014   |   By - GBI Research
GBI Research, a leading business intelligence provider, has released its latest research report: “Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany”. Due to the poor prognosis under currently available treatments, therapies with high potency are in strong demand in the...
$3500
Vaccinex, Inc. - Product Pipeline Review - 2014
May 2014   |   By - Global Markets Direct
Vaccinex, Inc. - Product Pipeline Review - 2014 Summary Global Markets Directs, Vaccinex, Inc. - Product Pipeline Review - 2014, provides an overview of the Vaccinex, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Vaccinex, Inc.s, complete with comparative analysis at various stages,...
$1500
Wellstat Vaccines, LLC - Product Pipeline Review - 2014
May 2014   |   By - Global Markets Direct
Wellstat Vaccines, LLC - Product Pipeline Review - 2014 Summary Global Markets Directs, Wellstat Vaccines, LLC - Product Pipeline Review - 2014, provides an overview of the Wellstat Vaccines, LLCs pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Wellstat Vaccines, LLCs, complete with comparative...
$1500
Vaccines Markets in China
May 2014   |   By - Asia Market Information & Development Company
China's demand for Vaccines has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and...
$4000
Global and China Therapeutic Vaccines Industry 2014 Market Research Report
Apr 2014   |   By - QYResearch
The report firstly introduced Therapeutic Vaccines basic information included Therapeutic Vaccines definition Therapeutic Vaccines classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Military Infrared (EO/IR) Systemss industry policy...
$2200
Global and China Seasonal Influenza Vaccine Industry 2014 Market Research Report
Apr 2014   |   By - QYResearch
The report firstly introduced Seasonal Influenza Vaccine basic information included Seasonal Influenza Vaccine definition Seasonal Influenza Vaccine classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Military Infrared (EO/IR) Systemss...
$2200
Global Influenza (Flu) Vaccine Market: Trends & Opportunities (2014-19)
Apr 2014   |   By - Daedal Research
With the advancement in technology and discovery of new products in the field of medical sciences, vaccines have gained crucial position in the pharmaceutical industry. Vaccines are considered as the most effective health intervention ever developed, saving innumerable lives. The vaccine market is growing at a steady pace, mainly because of the various existing and emerging diseases which...
$800
Meningococcal Vaccines Market (Polysaccharide, Conjugate, and Combination Vaccines, along with Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Apr 2014   |   By - Transparency Market Research
The global meningococcal vaccines market is studied on the basis of vaccine types such as polysaccharide, conjugate and combination vaccines. The vaccine types are further segmented into different brands. The report also highlights and analyzes various brands under pipeline segment, namely, Bexsero, MnB rLP2806 and NmVac-4DT. A detailed market analysis and forecast for these segments has been...
$4795
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Global Drug Forecast and Market Analysis to 2022
Mar 2014   |   By - GlobalData
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Global Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently low....
$10995
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - US Drug Forecast and Market Analysis to 2022
Mar 2014   |   By - GlobalData
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - US Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently low....
$4995
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - 5EU Drug Forecast and Market Analysis to 2022
Mar 2014   |   By - GlobalData
t the traditional target population of adolescent girls remain persistently low. Initially HPV vaccines were developed and marketed solely to protect against cervical cancer. In recent years the role of HPV in other cancers has been increasingly recognized which has facilitated a shift towards vaccinating a wider population, most significant has been the inclusion of males in routine vaccine...
$6995
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Japan Drug Forecast and Market Analysis to 2022
Mar 2014   |   By - GlobalData
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Japan Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently low....
$4995
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Australia Drug Forecast and Market Analysis to 2022
Mar 2014   |   By - GlobalData
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Australia Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently...
$4995
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Canada Drug Forecast and Market Analysis to 2022
Mar 2014   |   By - GlobalData
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Canada Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently low....
$4995
Gardasil (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022
Mar 2014   |   By - GlobalData
Gardasil (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently low. Initially HPV...
$3495
Cervarix (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022
Mar 2014   |   By - GlobalData
Cervarix (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently low. Initially HPV...
$3495
 
Displaying 1 to 30 (of 206 records)

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData

Popular Categories

 

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us

Upcoming Reports